Publication | Open Access
The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
15
Citations
19
References
2022
Year
The efficacy of dapagliflozin was demonstrated by its ability to improve diabetes, prevent nephropathy exacerbation, and reduce symptomatic reactions. The low rate of adverse reactions makes dapagliflozin a very safe medication.
| Year | Citations | |
|---|---|---|
Page 1
Page 1